Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):10S-18S; discussion 18S-20S.

Antidepressant options: venlafaxine in perspective.

Author information

1
Western Psychiatric Institute and Clinic, University of Pittsburgh, Pennsylvania, USA.

Abstract

Depression is often related to disturbances of norepinephrine and serotonin neurochemical systems within the brain that affect functional neurobehavioral systems. Classes of antidepressant agents have been developed that directly affect proposed brain neurochemical alterations. Many of the differences among antidepressant agents, particularly in safety and tolerability, can be attributed to their differing effects on receptor blockade and neurotransmitter reuptake. The overall goal of antidepressant treatment is complete recovery, and three phases of treatment have been delineated. Because of the recurrent and potentially chronic nature of depression, safety and tolerability of available treatments are especially important. An overview of antidepressant options is presented, with a particular focus on venlafaxine.

PMID:
8784644
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center